The Epigenomic Market is expected to register a CAGR of 18.2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The Epigenomic Market report covers analysis By Product Type (Reagents, Kits, Enzymes); Application (Pharmaceutical, Diagnostics). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Epigenomic Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Epigenomic Market Segmentation
Product Type- Reagents
- Kits
- Enzymes
- Pharmaceutical
- Diagnostics
Strategic Insights
Epigenomic Market Growth Drivers- Rising number of cancer cases: The rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, is the primary driver for the epigenomic market. Epigenetic modifications play a crucial role in the development and progression of these diseases, thereby creating demand for epigenomic research to better understand their mechanisms and develop targeted treatments.
- Advances in Epigenetic Research: Continuous developments in epigenetics research and technologies, including next-generation sequencing (NGS) and CRISPR-based gene editing, are speeding up the growth of the epigenomic market. These advances allow for better resolution and efficiency in epigenetic modification analysis, hence creating demand for epigenomic tools and services.
- Growing Focus on Personalized Medicine: Personalized medicine, where treatments are tailored to an individual's unique genetic and epigenetic profile, is gaining attention. The ability to study epigenomic changes helps in better understanding the response of individuals to treatments and thus fosters the development of more targeted and effective therapies.
- Incorporation of epigenomics: The incorporation of epigenomics in genomics about diseases is one rapidly increasing phenomenon. The combination of genomic information - DNA sequence through epigenetic information - the DNA modification hence be far more profound when considering factors like genetics and environment contributing towards a disease and even coming up with better therapeutic mechanisms.
- Developing non-invasive epigenetic diagnostics: There is a trend towards developing non-invasive epigenetic diagnostics. Liquid biopsies that look at DNA and RNA in blood samples are now increasingly being used to identify early stages of cancer, and many other diseases can now be diagnosed at the early stage using less invasive, cost-effective diagnostic approaches.
- Increased application in cancer research and treatment: Epigenomics is increasingly becoming important in cancer research, particularly in the identification of biomarkers for early detection, prognosis, and treatment response. The ability to monitor and modify epigenetic changes in cancer cells opens new avenues for personalized cancer therapies and immunotherapies.
- Epigenetic Therapeutics: Epigenetic drug development is one of the upcoming opportunities in the market. There are drugs that modify gene expression through DNA methylation enzymes and histone modification, with a potential to address many diseases, including cancers, neurodegenerative diseases, and autoimmune disorders.
- Advances in Epigenetic Biomarkers: Novel epigenetic biomarkers discovery and validation represent an area of major opportunities. Biomarkers linked with DNA methylation, histone modifications, and microRNA expression will be further considered for the earliest possible disease detection, prognosis, and monitoring treatment. This should unlock many opportunities in diagnostics.
- Investing into Strategic Research: More and more public and private investment in epigenetic research is creating an opportunity for market expansion. Governments, research institutions, and pharmaceutical companies are putting resources into research to find out the mechanisms of epigenetics in health and disease, and innovation in epigenomic tools and therapies will follow.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Epigenomic Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Epigenomic Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Key companies of this market are: Abbott Laboratories, Boehringer Ingelheim International GmbH, Agilent Technologies Inc., Bayer AG, Thermo Fisher Scientific Inc., Epizyme Inc., Abcam plc, Zymo Research Corporation, Merck KGaA.
Key future trends in this market are - Integration of Epigenomics in Drug Development, Focus on Biomarker Discovery, Expansion of Research Funding
The Epigenomic Market is estimated to witness a CAGR of 18.2% from 2023 to 2031.
The major factors driving the market are: Rising prevalence of cancer, Increasing government funding, Integration of AI in epigenomics
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Epigenomic Market - By Product Type
1.3.2 Epigenomic Market - By Application
1.3.3 Epigenomic Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. EPIGENOMIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. EPIGENOMIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. EPIGENOMIC MARKET - GLOBAL MARKET ANALYSIS
6.1. EPIGENOMIC - GLOBAL MARKET OVERVIEW
6.2. EPIGENOMIC - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. EPIGENOMIC MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. REAGENTS
7.3.1. Overview
7.3.2. reagents Market Forecast and Analysis
7.4. KITS
7.4.1. Overview
7.4.2. kits Market Forecast and Analysis
7.5. ENZYMES
7.5.1. Overview
7.5.2. enzymes Market Forecast and Analysis
8. EPIGENOMIC MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. PHARMACEUTICAL
8.3.1. Overview
8.3.2. Pharmaceutical Market Forecast and Analysis
8.4. DIAGNOSTICS
8.4.1. Overview
8.4.2. Diagnostics Market Forecast and Analysis
9. EPIGENOMIC MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Epigenomic Market Overview
9.1.2 North America Epigenomic Market Forecasts and Analysis
9.1.3 North America Epigenomic Market Forecasts and Analysis - By Product Type
9.1.4 North America Epigenomic Market Forecasts and Analysis - By Application
9.1.5 North America Epigenomic Market Forecasts and Analysis - By Countries
9.1.5.1 United States Epigenomic Market
9.1.5.1.1 United States Epigenomic Market by Product Type
9.1.5.1.2 United States Epigenomic Market by Application
9.1.5.2 Canada Epigenomic Market
9.1.5.2.1 Canada Epigenomic Market by Product Type
9.1.5.2.2 Canada Epigenomic Market by Application
9.1.5.3 Mexico Epigenomic Market
9.1.5.3.1 Mexico Epigenomic Market by Product Type
9.1.5.3.2 Mexico Epigenomic Market by Application
9.2. EUROPE
9.2.1 Europe Epigenomic Market Overview
9.2.2 Europe Epigenomic Market Forecasts and Analysis
9.2.3 Europe Epigenomic Market Forecasts and Analysis - By Product Type
9.2.4 Europe Epigenomic Market Forecasts and Analysis - By Application
9.2.5 Europe Epigenomic Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Epigenomic Market
9.2.5.1.1 Germany Epigenomic Market by Product Type
9.2.5.1.2 Germany Epigenomic Market by Application
9.2.5.2 France Epigenomic Market
9.2.5.2.1 France Epigenomic Market by Product Type
9.2.5.2.2 France Epigenomic Market by Application
9.2.5.3 Italy Epigenomic Market
9.2.5.3.1 Italy Epigenomic Market by Product Type
9.2.5.3.2 Italy Epigenomic Market by Application
9.2.5.4 Spain Epigenomic Market
9.2.5.4.1 Spain Epigenomic Market by Product Type
9.2.5.4.2 Spain Epigenomic Market by Application
9.2.5.5 United Kingdom Epigenomic Market
9.2.5.5.1 United Kingdom Epigenomic Market by Product Type
9.2.5.5.2 United Kingdom Epigenomic Market by Application
9.2.5.6 Rest of Europe Epigenomic Market
9.2.5.6.1 Rest of Europe Epigenomic Market by Product Type
9.2.5.6.2 Rest of Europe Epigenomic Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Epigenomic Market Overview
9.3.2 Asia-Pacific Epigenomic Market Forecasts and Analysis
9.3.3 Asia-Pacific Epigenomic Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Epigenomic Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Epigenomic Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Epigenomic Market
9.3.5.1.1 Australia Epigenomic Market by Product Type
9.3.5.1.2 Australia Epigenomic Market by Application
9.3.5.2 China Epigenomic Market
9.3.5.2.1 China Epigenomic Market by Product Type
9.3.5.2.2 China Epigenomic Market by Application
9.3.5.3 India Epigenomic Market
9.3.5.3.1 India Epigenomic Market by Product Type
9.3.5.3.2 India Epigenomic Market by Application
9.3.5.4 Japan Epigenomic Market
9.3.5.4.1 Japan Epigenomic Market by Product Type
9.3.5.4.2 Japan Epigenomic Market by Application
9.3.5.5 South Korea Epigenomic Market
9.3.5.5.1 South Korea Epigenomic Market by Product Type
9.3.5.5.2 South Korea Epigenomic Market by Application
9.3.5.6 Rest of Asia-Pacific Epigenomic Market
9.3.5.6.1 Rest of Asia-Pacific Epigenomic Market by Product Type
9.3.5.6.2 Rest of Asia-Pacific Epigenomic Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Epigenomic Market Overview
9.4.2 Middle East and Africa Epigenomic Market Forecasts and Analysis
9.4.3 Middle East and Africa Epigenomic Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Epigenomic Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Epigenomic Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Epigenomic Market
9.4.5.1.1 South Africa Epigenomic Market by Product Type
9.4.5.1.2 South Africa Epigenomic Market by Application
9.4.5.2 Saudi Arabia Epigenomic Market
9.4.5.2.1 Saudi Arabia Epigenomic Market by Product Type
9.4.5.2.2 Saudi Arabia Epigenomic Market by Application
9.4.5.3 U.A.E Epigenomic Market
9.4.5.3.1 U.A.E Epigenomic Market by Product Type
9.4.5.3.2 U.A.E Epigenomic Market by Application
9.4.5.4 Rest of Middle East and Africa Epigenomic Market
9.4.5.4.1 Rest of Middle East and Africa Epigenomic Market by Product Type
9.4.5.4.2 Rest of Middle East and Africa Epigenomic Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Epigenomic Market Overview
9.5.2 South and Central America Epigenomic Market Forecasts and Analysis
9.5.3 South and Central America Epigenomic Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Epigenomic Market Forecasts and Analysis - By Application
9.5.5 South and Central America Epigenomic Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Epigenomic Market
9.5.5.1.1 Brazil Epigenomic Market by Product Type
9.5.5.1.2 Brazil Epigenomic Market by Application
9.5.5.2 Argentina Epigenomic Market
9.5.5.2.1 Argentina Epigenomic Market by Product Type
9.5.5.2.2 Argentina Epigenomic Market by Application
9.5.5.3 Rest of South and Central America Epigenomic Market
9.5.5.3.1 Rest of South and Central America Epigenomic Market by Product Type
9.5.5.3.2 Rest of South and Central America Epigenomic Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. EPIGENOMIC MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. AGILENT TECHNOLOGIES INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BAYER AG
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. THERMO FISHER SCIENTIFIC INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. EPIZYME INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ABCAM PLC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ZYMO RESEARCH CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MERCK KGAA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. EPIGENOMICS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. Abbott Laboratories
2. Boehringer Ingelheim International GmbH
3. Agilent Technologies Inc.
4. Bayer AG
5. Thermo Fisher Scientific Inc.
6. Epizyme Inc.
7. Abcam plc
8. Zymo Research Corporation
9. Merck KGaA
10. Epigenomics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For